Manufacturers Life Insurance Company, The Cerus Corp Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Cerus Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 69,655 shares of CERS stock, worth $114,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,655
Previous 71,116 2.05%
Holding current value
$114,930
Previous $123,000 13.01%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$1.52 - $2.03 $2,220 - $2,965
-1,461 Reduced 2.05%
69,655 $107,000
Q3 2024

Nov 13, 2024
SELL
$1.7 - $2.39 $3,835 - $5,391
-2,256 Reduced 3.07%
71,116 $123,000
Q2 2024

Aug 14, 2024
BUY
$1.62 - $2.04 $11,678 - $14,706
7,209 Added 10.9%
73,372 $129,000
Q1 2024

May 14, 2024
SELL
$1.66 - $2.42 $7,380 - $10,759
-4,446 Reduced 6.3%
66,163 $125,000
Q4 2023

Feb 13, 2024
SELL
$1.25 - $2.35 $4,353 - $8,185
-3,483 Reduced 4.7%
70,609 $152,000
Q2 2023

Aug 11, 2023
BUY
$1.79 - $2.9 $10,892 - $17,646
6,085 Added 8.95%
74,092 $182,000
Q4 2022

Aug 11, 2023
SELL
$3.38 - $4.22 $483 - $603
-143 Reduced 0.21%
68,007 $248,000
Q4 2022

Feb 13, 2023
SELL
$3.38 - $4.22 $483 - $603
-143 Reduced 0.21%
68,007 $248,000
Q3 2022

Aug 11, 2023
SELL
$3.43 - $5.83 $5,254 - $8,931
-1,532 Reduced 2.2%
68,150 $245,000
Q3 2022

Nov 03, 2022
SELL
$3.43 - $5.83 $5,254 - $8,931
-1,532 Reduced 2.2%
68,150 $245,000
Q2 2022

Aug 11, 2023
SELL
$4.41 - $5.69 $1,380 - $1,780
-313 Reduced 0.45%
69,682 $368,000
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $1,380 - $1,780
-313 Reduced 0.45%
69,682 $369,000
Q1 2022

Aug 11, 2023
BUY
$4.81 - $6.99 $9,562 - $13,896
1,988 Added 2.92%
69,995 $384,000
Q1 2022

May 20, 2022
SELL
$4.81 - $6.99 $84,256 - $122,443
-17,517 Reduced 20.02%
69,995 $384,000
Q4 2021

Feb 16, 2022
SELL
$5.97 - $7.93 $16,345 - $21,712
-2,738 Reduced 3.03%
87,512 $596,000
Q3 2021

Nov 12, 2021
SELL
$4.79 - $6.68 $30,861 - $43,039
-6,443 Reduced 6.66%
90,250 $550,000
Q2 2021

Aug 12, 2021
BUY
$5.35 - $6.35 $14,755 - $17,513
2,758 Added 2.94%
96,693 $571,000
Q1 2021

May 03, 2021
SELL
$5.68 - $7.87 $26,343 - $36,501
-4,638 Reduced 4.71%
93,935 $565,000
Q4 2020

Feb 12, 2021
BUY
$5.25 - $8.56 $18,952 - $30,901
3,610 Added 3.8%
98,573 $682,000
Q3 2020

Nov 09, 2020
SELL
$5.78 - $7.47 $9,028 - $11,668
-1,562 Reduced 1.62%
94,963 $594,000
Q2 2020

Aug 10, 2020
BUY
$4.5 - $7.02 $3,802 - $5,931
845 Added 0.88%
96,525 $629,000
Q1 2020

May 15, 2020
BUY
$2.87 - $5.49 $32,224 - $61,641
11,228 Added 13.3%
95,680 $445,000
Q4 2019

Feb 14, 2020
SELL
$3.84 - $4.86 $7,484 - $9,472
-1,949 Reduced 2.26%
84,452 $356,000
Q2 2019

Aug 14, 2019
SELL
$4.51 - $6.6 $7,491 - $10,962
-1,661 Reduced 1.89%
86,401 $486,000
Q1 2019

May 13, 2019
BUY
$5.16 - $6.85 $30,836 - $40,935
5,976 Added 7.28%
88,062 $548,000
Q4 2018

Feb 14, 2019
SELL
$4.89 - $7.16 $24,308 - $35,592
-4,971 Reduced 5.71%
82,086 $416,000
Q3 2018

Nov 14, 2018
SELL
$6.89 - $7.78 $66,357 - $74,929
-9,631 Reduced 9.96%
87,057 $628,000
Q2 2018

Aug 14, 2018
BUY
$5.19 - $7.25 $3,108 - $4,342
599 Added 0.62%
96,688 $644,000
Q1 2018

May 15, 2018
BUY
$3.56 - $5.74 $17,614 - $28,401
4,948 Added 5.43%
96,089 $527,000
Q4 2017

Feb 08, 2018
BUY
$2.76 - $3.95 $9,618 - $13,765
3,485 Added 3.98%
91,141 $308,000
Q3 2017

Nov 14, 2017
BUY
$2.22 - $2.73 $194,596 - $239,300
87,656
87,656 $240,000

Others Institutions Holding CERS

# of Institutions
159
Shares Held
146M
Call Options Held
48.6K
Put Options Held
8.7K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $292M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email